tiprankstipranks

Bradley Cole Insider Profile

4 Followers
Bradley Cole, Director at Kiniksa Pharmaceuticals, holds 7.17K shares in Kiniksa Pharmaceuticals (Ticker: KNSA), holds 32.98K shares in Castle Biosciences (Ticker: CSTL), holds 10.19K shares in Exact Sciences (Ticker: EXAS).
tipranks
Bradley Cole

Bradley Cole
Kiniksa Pharmaceuticals (KNSA)
Director

Ranked #71,777 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-13.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
66.01%
33.99%
A breakdown of Bradley Cole's holdings

Insider Roles

Castle Biosciences
(CSTL)
Director
Kiniksa Pharmaceuticals
(KNSA)
Director
Roles that Bradley Cole holds in companies

Most Profitable Insider Trade

Stock:
Kiniksa Pharmaceuticals
(KNSA)
Rating:Informative Sell
Date:Jul 31, 2026 - Today
Return:-4.80%
The most profitable trade made by Bradley Cole

Bradley Cole's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Kiniksa Pharmaceuticals
Jul 31, 2026
Director
Uninformative Sell
$558.77K
GHDX
Genomic Health
Nov 14, 2019
Uninformative Sell
$0.00
EXAS
Exact Sciences
Feb 21, 2020
Uninformative Sell
2.74M
$1.07M
Castle Biosciences
May 27, 2026
Director
Uninformative Buy
275.39K
$1.09M
List of latest transactions for each holding click on a transaction to see Bradley Cole's performance on stock

Bradley Cole insider profile FAQ

What is the percentage of profitable transactions made by Bradley Cole?
The percentage of profitable transactions made by Bradley Cole is 0%.
    What is the average return per transaction made by Bradley Cole?
    The average return per transaction made by Bradley Cole is -13.10%.
      What stocks does Bradley Cole hold?
      Bradley Cole holds: KNSA, GHDX, EXAS, CSTL stocks.
        What was Bradley Cole’s latest transaction?
        Bradley Cole latest transaction was an Uninformative Sell of ―.
          What was Bradley Cole's most profitable transaction?
          Bradley Cole’s most profitable transaction was an Informative Sell of KNSA stock on July 31, 2026. The return on the trade was -4.80%.
            What is Bradley Cole's role in Kiniksa Pharmaceuticals?
            Bradley Cole's role in Kiniksa Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.